CA2006118A1 - Peptides, anticorps diriges contre ces peptides, et procedes de detection et de dosage de papillomavirus hpv16 - Google Patents

Peptides, anticorps diriges contre ces peptides, et procedes de detection et de dosage de papillomavirus hpv16

Info

Publication number
CA2006118A1
CA2006118A1 CA002006118A CA2006118A CA2006118A1 CA 2006118 A1 CA2006118 A1 CA 2006118A1 CA 002006118 A CA002006118 A CA 002006118A CA 2006118 A CA2006118 A CA 2006118A CA 2006118 A1 CA2006118 A1 CA 2006118A1
Authority
CA
Canada
Prior art keywords
peptide
antibodies
peptides
hpv16
coupled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002006118A
Other languages
English (en)
French (fr)
Inventor
Guy De Martynoff
Robert Brasseur
Marc Zeicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2006118A1 publication Critical patent/CA2006118A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081DNA viruses
    • C07K16/084Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002006118A 1988-12-23 1989-12-20 Peptides, anticorps diriges contre ces peptides, et procedes de detection et de dosage de papillomavirus hpv16 Abandoned CA2006118A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8817097A FR2641081A1 (https=) 1988-12-23 1988-12-23
FR8817097 1988-12-23

Publications (1)

Publication Number Publication Date
CA2006118A1 true CA2006118A1 (fr) 1990-06-23

Family

ID=9373358

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002006118A Abandoned CA2006118A1 (fr) 1988-12-23 1989-12-20 Peptides, anticorps diriges contre ces peptides, et procedes de detection et de dosage de papillomavirus hpv16

Country Status (4)

Country Link
EP (1) EP0375555A1 (https=)
JP (1) JPH02291297A (https=)
CA (1) CA2006118A1 (https=)
FR (1) FR2641081A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111187338A (zh) * 2014-06-12 2020-05-22 Ra制药公司 补体活性的调节

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907721A1 (de) * 1989-03-10 1990-09-20 Behringwerke Ag Immunogene regionen auf dem e7-protein des humanen papillomvierus typ 16
EP0451550A3 (en) * 1990-03-20 1991-11-06 Behringwerke Aktiengesellschaft Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
SE9001705D0 (sv) * 1990-05-11 1990-05-11 Medscand Ab Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
US5932412A (en) * 1990-05-11 1999-08-03 Euro-Diagnostica Ab Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
KR100252371B1 (ko) * 1990-12-12 2000-05-01 포터 더글라스 서브유니트 파필로마비루스 백신 및 그들에 사용하기 위한 펩티드
US6183745B1 (en) 1990-12-12 2001-02-06 The University Of Queensland Subunit papilloma virus vaccine and peptides for use therein
FR2670797A1 (fr) * 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
ES2193133T3 (es) * 1991-07-13 2003-11-01 Dade Behring Marburg Gmbh Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.
IL105554A (en) 1992-05-05 1999-08-17 Univ Leiden Peptides of human papillomavirus for use in preparations elicit a human T cell response
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
AUPM358894A0 (en) * 1994-01-31 1994-02-24 Csl Limited Modified papilloma virus l2 protein and vlps formed therefrom
GB9420146D0 (en) * 1994-10-06 1994-11-23 Cancer Res Campaign Tech Papillomavirus vaccine
DE19925235A1 (de) * 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
DE19925199A1 (de) * 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
FR2794370B1 (fr) * 1999-06-03 2003-10-17 Biovector Therapeutics Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
FR2794371B1 (fr) * 1999-10-07 2004-06-18 Biovector Therapeutics Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination
CN113533733A (zh) * 2021-07-14 2021-10-22 上海交通大学 用于检测人血中aep蛋白水平的化学发光免疫检测试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586428B1 (fr) * 1985-08-26 1988-11-25 Pasteur Institut Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111187338A (zh) * 2014-06-12 2020-05-22 Ra制药公司 补体活性的调节

Also Published As

Publication number Publication date
FR2641081A1 (https=) 1990-06-29
JPH02291297A (ja) 1990-12-03
EP0375555A1 (fr) 1990-06-27

Similar Documents

Publication Publication Date Title
CA2006118A1 (fr) Peptides, anticorps diriges contre ces peptides, et procedes de detection et de dosage de papillomavirus hpv16
Grauballe et al. Optimized enzyme‐linked immunosorbent assay for detection of human and bovine rotavirus in stools: Comparison with electron‐microscopy, immunoelectro‐osmophoresis, and fluorescent antibody techniques
EP0277437B1 (fr) Agent viral de l'hépatite NANB, antigène et réactif immunologique
Luostarinen et al. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11
FI97426C (fi) Menetelmä ihmisen papilloomaviruksen (HPV) toteamiseksi diagnostista käyttöä varten
Anil et al. Monoclonal antibodies developed for sensitive detection and comparison of white spot syndrome virus isolates in India
Lehtinen et al. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later
Cowsert et al. Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies
Hornsleth et al. Detection of respiratory syncytial virus in nasopharyngeal secretions by ELISA: comparison with fluorescent antibody technique
FR2586428A1 (fr) Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus
Neureiter et al. Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate
Di Lonardo et al. Egg yolk antibodies against the E7 oncogenic protein of human papillomavirus type 16
JP2001505778A (ja) HIV感染の初期の検出のための未変性の(non―dentured)HIV抗原を使用する新規のEIA試験
Sun et al. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma
US4748109A (en) Assay method and reagent to determine antibodies to papillomavirus virions
EP2470907B1 (fr) Proteines utilisees pour le diagnostic d'une borreliose de lyme
FR2690921A1 (fr) Polypeptides de synthèse appartenant au virus de l'hépatite C (VHC) et utilisables notamment pour détecter ce dernier.
FR2728904A1 (fr) Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
FR2606515A1 (fr) Procede pour l'isolement d'un nouvel agent viral et de l'antigene qui lui est associe, agent viral et antigene obtenus par ce procede et procede de detection dudit antigene a l'aide d'un reactif immunologique approprie
FR2949473A1 (fr) Proteines utilisees pour le diagnostic d'une borreliose de lyme
EP1135684A1 (en) IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES
FR2573533A1 (fr) Procede de detection ou de titration d'immunoglobulines dirigees contre un antigene particulier et dispositif pour la mise en oeuvre de ce procede.
FR3109446A1 (fr) Detection immunologique du sars-cov2 dans un echantillon salivaire
JP2004107219A (ja) モノクローナル抗体およびその利用方法
JP2003083976A (ja) HBs抗原測定試薬

Legal Events

Date Code Title Description
FZDE Discontinued